When side effect becomes the effect: Efficacy of capecitabine in refractory psoriasis

Dermatol Ther. 2018 Nov;31(6):e12629. doi: 10.1111/dth.12629. Epub 2018 Sep 19.

Authors

Yusuf Karakas¹, Secil Vural², Omer Diker³, Omer Dizdar³

Affiliations

¹ Medical Oncology Clinic, Hakkari State Hospital, Hakkari, Turkey.
² Dermatology Department, Ludwig Maximilian University, Munich, Germany.
³ Medical Oncology Department, Hacettepe University Oncology Institute, Ankara, Turkey.

PMID: 30230162
DOI: 10.1111/dth.12629

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antimetabolites, Antineoplastic / adverse effects
Antimetabolites, Antineoplastic / therapeutic use*
Capecitabine / adverse effects
Capecitabine / therapeutic use*
Humans
Male
Middle Aged
Neoplasm Metastasis
Psoriasis / complications
Psoriasis / diagnosis
Psoriasis / drug therapy*
Skin / drug effects*
Skin / pathology
Stomach Neoplasms / complications
Stomach Neoplasms / drug therapy*
Stomach Neoplasms / pathology
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Capecitabine